Facebook
Twitter
LinkedIn
Forward
Obesity Medicine 2023 - Spring Obesity Summit
|
This presentation will provide clinicians a brief scientific overview of 10 of the most controversial topics covered, discussed, and published in OMA’s Clinical Practice Statements, including:
|
We are at a unique place in obesity care history where anti-obesity medications (AOMs) are showing promising, clinically significant weight loss for persons with obesity.
|
OMA Clinical Practice Statement Updates - Harold Bays, MD, FOMA, Lydia Alexander, MD, FOMA, Karlijn Burridge, PA-C, Suzanne Cuda, MDCME/CE Expiration Date: 3/19/25
|
We are amidst a paradigm shift in obesity treatment, spurred by the introduction of newer, highly effective anti-obesity medications.
|
This session will discuss strategies to increase access to obesity care while mitigating provider burnout.
|
This session covers the employer health benefit landscape and how it has changed over the last five years due to COVID, new treatments, technology, and competition.
|
In this session, co-presented by a primary care and an obesity-focused tertiary care provider, we will review barriers and facilitators to pediatric obesity treatment in primary and tertiary care s
|
70% of Americans have pre-obesity or the serious, chronic, and relapsing disease of obesity.
|
The OMA Obesity Algorithm has finished being revised for 2023 and is now available. In this webinar, Dr. Justin Tondt will highlight the changes from the previous edition.
|